Verastem (VSTM) Other Non-Current Liabilities (2012 - 2025)
Verastem's quarterly Other Non-Current Liabilities came in at $35.6 million in Q4 2025, down 38.75% year-on-year from $58.2 million in Q4 2024, and down 26.18% quarter-over-quarter from $48.3 million in Q3 2025.
Verastem has reported Other Non-Current Liabilities for 11 years, with the latest figure at $35.6 million in Q4 2025.
- For the quarter ending Q4 2025, Other Non-Current Liabilities fell 38.75% year-over-year to $35.6 million; the trailing twelve-month figure through Dec 2025 stood at $35.6 million (down 38.75% YoY), and the FY2025 full-year result was $35.6 million, down 38.75% from the prior year.
- Other Non-Current Liabilities for Q4 2025 stood at $35.6 million, down from $48.3 million in the prior quarter.
- The five-year high for Other Non-Current Liabilities was $58.2 million in Q4 2024, with the low at $51000.0 in Q3 2023.
- Average Other Non-Current Liabilities over 3 years is $32.9 million, with a median of $35.6 million recorded in 2025.
- Year-over-year, Other Non-Current Liabilities surged 51150.98% in 2024 and sank 38.75% in 2025.
- Tracing VSTM's Other Non-Current Liabilities over 3 years: stood at $51000.0 in 2023, then jumped by 114015.69% to $58.2 million in 2024, then plunged by 38.75% to $35.6 million in 2025.
- The last three Other Non-Current Liabilities figures came in at $35.6 million (Q4 2025), $48.3 million (Q3 2025), and $7.6 million (Q2 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Quantum Biopharma | 1,216,509.61 Bn | 1,216,509.61 Bn | - |
| 2 | Alterity Therapeutics | 764,224.41 Bn | 764,224.38 Bn | - |
| 3 | Legend Biotech | 2,716.00 Bn | 2,715.71 Bn | 242.10 Mn |
| 4 | Nanobiotix | 2,248.83 Bn | 2,248.77 Bn | - |
| 5 | Akari Therapeutics | 1,951.18 Bn | 1,951.17 Bn | - |
| 6 | Vertex Pharmaceuticals | 113.69 Bn | 106.44 Bn | 2.59 Bn |
| 7 | Evaxion A | 64.16 Bn | 64.14 Bn | - |
| 8 | Regeneron Pharmaceuticals | 63.94 Bn | 55.18 Bn | 3.31 Bn |
| 9 | Alnylam Pharmaceuticals | 40.13 Bn | 37.12 Bn | 959.66 Mn |
| 10 | Verastem | 425.60 Mn | 243.93 Mn | 15.90 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 35.65 Mn |
| Sep 30, 2025 | 48.29 Mn |
| Jun 30, 2025 | 7.55 Mn |
| Mar 31, 2025 | 54.75 Mn |
| Dec 31, 2024 | 58.20 Mn |
| Sep 30, 2024 | 26.14 Mn |
| Sep 30, 2023 | 51,000.00 |
| Jun 30, 2020 | 870,000.00 |
| Mar 31, 2020 | 870,000.00 |
| Dec 31, 2019 | 870,000.00 |
| Sep 30, 2019 | 870,000.00 |
| Jun 30, 2019 | 500,000.00 |
| Mar 31, 2019 | 500,000.00 |
| Dec 31, 2018 | 1.12 Mn |
| Sep 30, 2018 | 566,000.00 |
| Jun 30, 2018 | 399,000.00 |
| Mar 31, 2018 | 101,000.00 |
| Dec 31, 2017 | 151,000.00 |
| Sep 30, 2017 | 201,000.00 |
| Jun 30, 2017 | 248,000.00 |
| Mar 31, 2017 | 295,000.00 |
| Sep 30, 2016 | 388,000.00 |
| Jun 30, 2016 | 430,000.00 |
| Mar 31, 2016 | 472,000.00 |
| Dec 31, 2015 | 516,000.00 |
| Sep 30, 2013 | 18,000.00 |
| Dec 31, 2012 | 58,000.00 |